FSL 1

• Description:

  TLR2/6 agonist (also a putative TLR10 ligand) . Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  1666.16

• Molecular Formula:

  C84H140N14O18S

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  322455-70-9